Annual report
7317.TEDINET S100W2DL
Period2024-04-01 → 2025-03-31
Filed2025-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥8.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥7.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥675m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥409m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥831m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥953m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥426m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥165m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥569m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥953m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥10.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.7bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.9bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.0bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.8bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥528m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥915m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥140m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥656m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥746m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥616m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥485m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥62m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥38m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥183m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥504m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥43m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥73.38 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.03 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.17 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.85 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.46 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥72.55 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.43 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥20.02 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥7.75 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.87 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥324.88 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥244.72 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥178.69 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥153.44 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥134.71 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 63.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.0% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 25.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,403 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,367 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,383 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 1,442 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 1,422 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥3.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥3.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥149m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥33m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥903m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥347m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥68m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥31m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥673m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥637m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥253m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥636m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥206m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥320m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥4m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥469m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.8bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥4.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥4.1bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.0bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥454m | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥29.89 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.74 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-15.16 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.2 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.67 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.55 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥9.61 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.19 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥10 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2.5 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥85.11 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥56.75 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥47.4 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥63.58 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥63.9 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 38.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 42.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.7% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -27.3% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 49.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,342,800 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,223,200 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,281,800 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,275,400 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,598,500 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 43 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 44 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 39 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 39 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 34 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2024-04-01 → 2025-03-31 | ¥129m |
| Otherother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥129m |
| Otherother segments | segment assets | at 2025-03-31 | ¥55m |
| Otherother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥31m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥18m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥1.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥318m |
| Medical Healthcarereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥193m |
| Medical Healthcarereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥83m |
| Medical Healthcarereportable segment | employees | at 2025-03-31 | 516 pure |
| Medical Healthcarereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.1bn |
| Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.1bn |
| Medical Healthcarereportable segment | segment assets | at 2025-03-31 | ¥4.8bn |
| Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Safety Systemreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥319m |
| Safety Systemreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥106m |
| Safety Systemreportable segment | employees | at 2025-03-31 | 877 pure |
| Safety Systemreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3.4bn |
| Safety Systemreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3.4bn |
| Safety Systemreportable segment | segment assets | at 2025-03-31 | ¥4.1bn |
| Safety Systemreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥253m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥512m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥189m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥44m |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥44m |
| Otherother segments | segment assets | at 2024-03-31 | ¥23m |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥19m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥944m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥295m |
| Medical Healthcarereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥297m |
| Medical Healthcarereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥116m |
| Medical Healthcarereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Healthcarereportable segment | segment assets | at 2024-03-31 | ¥3.9bn |
| Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Safety Systemreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥371m |
| Safety Systemreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥155m |
| Safety Systemreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Safety Systemreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Safety Systemreportable segment | segment assets | at 2024-03-31 | ¥5.0bn |
| Safety Systemreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥167m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥668m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥271m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| Medical Healthcarereportable segment | employees | at 2025-03-31 | 15 pure |
| Safety Systemreportable segment | employees | at 2025-03-31 | 18 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,481
| Item | Context | Value | Unit |
|---|---|---|---|
| Metrics description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | Original text (Japanese)中途採用者数 | |
| Metrics unit description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | Original text (Japanese)名 | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数 100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)後藤 倫啓 | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)大阪府大阪市天王寺区 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)後藤 匡啓 | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)東京都文京区 | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)オムロンヘルスケア株式会社 | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)京都府向日市寺戸町九ノ坪53番地 | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)ゴトウホールディング株式会社 | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)福井県大野市元町３番19号 | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)後藤 秀隆 | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)福井県福井市 | |
| Name major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口） | |
| Address major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８-12 | |
| Name major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)前田工繊株式会社 | |
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)福井県坂井市春江町沖布目第38号３番地 | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)三菱UFJモルガン・スタンレー証券株式会社 | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町１丁目９番２号 | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)栗本 英有 | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)愛知県一宮市 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)株主としての権利内容に何ら限定のない当社における標準となる株式であります。なお、１単元の株式数は100株であります。 | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)株式会社松屋アールアンドディ |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |